Clinical Trials Browser

Phase 2 × Stomach Neoplasms × bavituximab × Clear all

NCT04099641 2023-02-08

An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients

Phase 2 Completed

80 enrolled 14 charts

Gastrointestinal

Stomach Neoplasms